Aerogen is a world leader in acute care aerosol drug delivery. Aerogen technology has been in use for over 25 years, in more than 75 countries globally and is associated with over 200 clinical papers and publications.1 Aerogen vibrating mesh nebuliser technology has been used to treat 25 million patients in more than 75 countries worldwide.1
Aerogen is the partner of choice for the world’s leading ventilator companies for aerosol drug delivery.1 The company continues to leverage their expertise, research, technologies and partnerships to make the greatest possible difference to patient outcomes.
From critical care to emergency care, and across multiple ventilated and non-ventilated therapies, discover how Aerogen facilitates aerosol drug delivery at every stage of your patient’s respiratory therapy journey.2
References
1. Aerogen Data on File
2. 30-354 REV U Aerogen Solo Instruction Manual
